Bohren, Meghan A. http://orcid.org/0000-0002-4179-4682
Lorencatto, Fabiana http://orcid.org/0000-0003-4418-7957
Coomarasamy, Arri http://orcid.org/0000-0002-3261-9807
Althabe, Fernando http://orcid.org/0000-0002-7024-8701
Devall, Adam J.
Evans, Cherrie
Oladapo, Olufemi T. http://orcid.org/0000-0002-3371-5892
Lissauer, David http://orcid.org/0000-0002-7878-2327
Akter, Shahinoor http://orcid.org/0000-0002-5236-3597
Forbes, Gillian http://orcid.org/0000-0003-3816-6383
Thomas, Eleanor
Galadanci, Hadiza
Qureshi, Zahida
Fawcus, Sue
Hofmeyr, G. Justus
Al-beity, Fadhlun Alwy http://orcid.org/0000-0003-2416-6876
Kasturiratne, Anuradhani http://orcid.org/0000-0001-5260-2394
Kumarendran, Balachandran http://orcid.org/0000-0001-7786-5932
Mammoliti, Kristie-Marie
Vogel, Joshua P. http://orcid.org/0000-0002-3214-7096
Gallos, Ioannis http://orcid.org/0000-0002-2766-358X
Miller, Suellen
Clinical trials referenced in this document:
Documents that mention this clinical trial
Formative research to design an implementation strategy for a postpartum hemorrhage initial response treatment bundle (E-MOTIVE): study protocol
https://0-doi-org.brum.beds.ac.uk/10.1186/s12978-021-01162-3
Funding for this research was provided by:
Bill and Melinda Gates Foundation
Article History
Received: 8 April 2021
Accepted: 17 May 2021
First Online: 14 July 2021
Declarations
:
: This study has received or sought ethics approval from the following entities: United Kingdom: University of Birmingham STEM committee (Reference number: ERN_19-1557). Australia: University of Melbourne Medicine and Dentistry Human Ethics Sub-Committee (1956004). World Health Organization: Review Panel on Research Project Review Panel s (RP2), WHO Ethical Review Research Ethics Review Committee (WHO ERC; reference number: ERC.0003486). Nigeria: National Health Research Ethics Committee of Nigeria (NHREC) (Reference number: NHREC/01/01/2007)-07/04/2020). Kenya: University of Nairobi: KNH-UON ERC (P25/01/2020); Pharmacy and Poisons Board PPB/ECCT/20/06/06/2020(116), National Commission for Science, Technology and Innovation Nacosti P/21/8437. South Africa: Eastern Cape Department of Health (EC_202007_015); University of Cape Town Human Research Ethics Committee (HREC; reference number: 091/2020), Health Province of KwaZulu-Natal (NHRD reference number: KZ_202008_036), University of the Witwatersrand Human Research Ethics Committee-Medical (reference number: M200241). Tanzania: Muhimbili University of Health and Allied Sciences (MUHAS) (reference number: DA.282./298/01.C/); National Institute for Medical Research (NIMR) (Reference number: NIMR/HQ/R.8a/Vol IX/3501). Sri Lanka: Ethics Review Committee of Faculty of Medicine, University of Kelaniya.
: Not applicable.
: Professor Suellen Miller’s University (University of California San Francisco) holds the license for the Trademark name “LifeWrap.” The LifeWrap is the name of one first-aid device used in refractory postpartum hemorrhage, the Non-pneumatic Anti-Shock Garment (NASG). The manufacturer of the LifeWrap NASG pays the University of California a royalty for the use of the name. Professor Justus Hofmeyr has conceived a re-usable device for postpartum blood loss monitoring, the ‘Safe Birth Tray’, which is under development by Equalize Health, a non-profit global health organization who hold the intellectual property. JH may in future benefit from sales of the device. The remaining authors declare that they have no competing interests.